JGP Global Gestao de Recursos Ltda. — 13F Holdings & Portfolio
CIK 1536562 · latest 13F-HR filed 2026-05-08
JGP Global Gestao de Recursos Ltda. manages $23.2M in 13F-reported U.S. long-equity assets across 29 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are STNE (28.98%), XP (21.35%), NU (14.62%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 0 new positions, exited 21, added to 5, and trimmed 15.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$23.2M
Long-equity book
29
Distinct positions
2026-03-31
Filed 2026-05-08
+0 / −21 / ↑5 / ↓15
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- XP INC - CLASS A$848.2K +20.7%
- JOHNSON & JOHNSON$81.8K +18.6%
- BRISTOL-MYERS SQUIBB CO$42.7K +12.9%
- GILEAD SCIENCES INC$39.9K +14.0%
- MCKESSON CORP$14.4K +6.2%
Top Trims
- STONECO LTD-A-$32.5M -82.9%
- NU HOLDINGS LTD/CAYMAN ISL-A-$1.5M -30.8%
- INCYTE CORP-$368.9K -41.1%
- BEIGENE LTD-ADR-$269.3K -34.6%
- INSMED INC-$223.0K -51.3%
Exited Positions
- NEW GOLD INC$80.0M
- SOLSTICE ADV MATERIALS INC$10.7M
- RANGE RESOURCES CORP$7.1M
- ISHARES MSCI BRAZIL CAPPED E$3.2M
- MAGNUM ICE CREAM CO NV$3.2M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | STONECO LTD-A | STNE | G85158106 | $6.7M | 28.98% | 475,123 | SH |
| 2 | XP INC - CLASS A | XP | G98239109 | $4.9M | 21.35% | 259,548 | SH |
| 3 | NU HOLDINGS LTD/CAYMAN ISL-A | NU | G6683N103 | $3.4M | 14.62% | 235,574 | SH |
| 4 | ELI LILLY & CO | LLY | 532457108 | $1.1M | 4.89% | 1,231 | SH |
| 5 | SOLSTICE ADV MATERIALS INC Put | SOLS | 83443Q103 | $760.0K | 3.28% | 2,000 | SH |
| 6 | ABBVIE INC | ABBV | 00287Y109 | $667.9K | 2.89% | 3,071 | SH |
| 7 | INCYTE CORP | INCY | 45337C102 | $529.0K | 2.28% | 5,620 | SH |
| 8 | JOHNSON & JOHNSON | JNJ | 478160104 | $521.1K | 2.25% | 2,132 | SH |
| 9 | BEIGENE LTD-ADR | ONC | 07725L102 | $508.1K | 2.19% | 1,711 | SH |
| 10 | BRISTOL-MYERS SQUIBB CO | BMY | 110122108 | $373.7K | 1.61% | 6,161 | SH |
| 11 | TAIWAN SEMICONDUCTOR-SP ADR | TSM | 874039100 | $350.8K | 1.52% | 1,038 | SH |
| 12 | THERMO FISHER SCIENTIFIC INC | TMO | 883556102 | $346.0K | 1.49% | 704 | SH |
| 13 | INTUITIVE SURGICAL INC | ISRG | 46120E602 | $345.7K | 1.49% | 750 | SH |
| 14 | GILEAD SCIENCES INC | GILD | 375558103 | $324.9K | 1.40% | 2,331 | SH |
| 15 | ABBOTT LABORATORIES | ABT | 002824100 | $317.7K | 1.37% | 3,094 | SH |
| 16 | NVIDIA CORP | NVDA | 67066G104 | $264.9K | 1.14% | 1,519 | SH |
| 17 | MCKESSON CORP | MCK | 58155Q103 | $245.8K | 1.06% | 284 | SH |
| 18 | VERTEX PHARMACEUTICALS INC | VRTX | 92532F100 | $239.8K | 1.04% | 537 | SH |
| 19 | MADRIGAL PHARMACEUTICALS INC | MDGL | 558868105 | $226.7K | 0.98% | 433 | SH |
| 20 | ZOETIS INC | ZTS | 98978V103 | $212.3K | 0.92% | 1,796 | SH |
| 21 | INSMED INC | INSM | 457669307 | $211.9K | 0.92% | 1,296 | SH |
| 22 | VNET GROUP INC-ADR | VNET | 90138A103 | $208.0K | 0.90% | 24,794 | SH |
| 23 | BOSTON SCIENTIFIC CORP | BSX | 101137107 | $205.4K | 0.89% | 3,273 | SH |
| 24 | STONECO LTD-A Call | STNE | G85158106 | $45.0K | 0.19% | 570 | SH |
| 25 | ISHARES MSCI EMERGING MARKET Call | EEM | 464287234 | $19.6K | 0.08% | 1,455 | SH |
| 26 | STONECO LTD-A Put | STNE | G85158106 | $18.8K | 0.08% | 570 | SH |
| 27 | ARM HOLDINGS PLC-ADR Call | ARM | 042068205 | $15.6K | 0.07% | 130 | SH |
| 28 | OI SA-ADR | — | 670851500 | $13.1K | 0.06% | 50,301 | SH |
| 29 | ISHARES MSCI EMERGING MARKET Call | EEM | 464287234 | $11.2K | 0.05% | 1,600 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-08 | $23.2M | 29 | 0001536562-26-000003 |
| 2025-12-31 | 2026-01-26 | $169.5M | 49 | 0001536562-26-000001 |